Chemesis International Inc. Announces Initial Deployment of its VICKI Artificial Intelligence Self-Checkout Solution at Atlanta International Airport
cannabis investing Chemesis International Inc. Subsidiary, Natural Ventures PR, LLC, to Remain Operational During COVID-19 Pandemic
cannabis investing Chemesis International Inc. Announces Closing of CDN $5,000,000 Private Placement and Settlement of Debt
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
